-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Adopting New Approaches for Relapsed/Refractory Follicular Lymphoma

Sponsor: an independent educational grant from Epizyme, Inc.
Program: Satellite Symposia
Hematology Disease Topics & Pathways:
Follicular Lymphoma, Adult, Diseases, Therapies, Adverse Events, B-Cell Lymphoma, Lymphoid Malignancies, Study Population, Clinically relevant
Friday, December 4, 2020: 3:00 PM-6:00 PM
Chair:
Loretta J. Nastoupil, MD, The University of Texas MD Anderson Cancer Center
Disclosures:
Nastoupil: Gilead/KITE: Honoraria; Bayer: Honoraria; TG Therapeutics: Honoraria, Research Funding; Genentech, Inc.: Honoraria, Research Funding; Celgene: Honoraria, Research Funding; LAM Therapeutics: Research Funding; Novartis: Honoraria, Research Funding; Janssen: Honoraria, Research Funding; Karus Therapeutics: Research Funding; Pfizer: Honoraria, Research Funding; Gamida Cell: Honoraria; Merck: Research Funding.
Speakers:
Connie Lee Batlevi, MD, PhD, Memorial Sloan Kettering Cancer Center and Matthew A. Lunning, DO, FACP, University of Nebraska Medical Center
Disclosures:
Batlevi: Life Sci, GLG, Juno/Celgene, Seattle Genetics, Kite: Consultancy; Janssen, Novartis, Epizyme, Xynomics, Bayer, Autolus, Roche/Genentech: Research Funding. Lunning: Gilead: Consultancy, Honoraria; Janssen: Consultancy, Honoraria; Karyopharm: Consultancy, Honoraria; Kite: Consultancy, Honoraria; Novartis: Consultancy, Honoraria; TG Therapeutics: Research Funding; Verastem: Consultancy, Honoraria; Acrotech: Consultancy; AstraZeneca: Consultancy, Honoraria; ADC Therapeutics: Consultancy; Curis: Research Funding; Beigene: Consultancy, Honoraria; Bristol Meyers Squibb: Consultancy, Honoraria, Research Funding; Aeratech: Consultancy, Honoraria; Legend: Consultancy.
Join us for Trivia Night! Compete against your peers through case-based challenges about relapsed/refractory follicular lymphoma. Test your skills selecting treatment and managing side effects as well as your knowledge of novel and emerging therapies. This will be a lively symposium with panel discussion and clinical pearls.
See more of: Satellite Symposia